Lyra Therapeutics • LYRA
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Maria Palasis, PhD$312.5M
Market Cap • 24/04/20242005
(há 19 anos)
2020
(4 years ago)
NASDAQ
Listagem
Watertown
Sede • Massachusetts58
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
LYRASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.